Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Halberd Corporation (OTC PINK:HALB)(“the Company”), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with Covid-19. CEO and Chairman of the Company, William A Hartman, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Mar 9, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody

0:00 12:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 12 minutes long.

When was this Stock Day Media episode published?

This episode was published on March 9, 2021.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!